113 related articles for article (PubMed ID: 17585118)
1. Effects of dosing interval on the pharmacokinetic interaction between oral small spherical activated charcoal and amlodipine in humans.
Tanaka C; Ohtani H; Tsujimoto M; Ohdo S; Taniguchi M; Mizooku Y; Saitoh Y; Kimura M; Uchimaru H; Irie S; Sawada Y
J Clin Pharmacol; 2007 Jul; 47(7):904-8. PubMed ID: 17585118
[No Abstract] [Full Text] [Related]
2. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
Abernethy DR
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
[TBL] [Abstract][Full Text] [Related]
3. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and haemodynamic interactions between amlodipine and losartan in human beings.
Park JW; Kim KA; Il Kim Y; Park JY
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):345-352. PubMed ID: 31058419
[TBL] [Abstract][Full Text] [Related]
5. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
Laine K; Kivistö KT; Laakso I; Neuvonen PJ
Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
7. [Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine].
Zuo XC; Yuan H; Zhang BK; Ng CM; Barrett JS; Yang GP; Huang ZJ; Pei Q; Guo R; Zhou YN; Jing NN; Di W
Yao Xue Xue Bao; 2012 Jul; 47(7):941-6. PubMed ID: 22993862
[TBL] [Abstract][Full Text] [Related]
8. CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine.
Naito T; Kubono N; Ishida T; Deguchi S; Sugihara M; Itoh H; Kanayama N; Kawakami J
Drug Metab Pharmacokinet; 2015 Dec; 30(6):419-24. PubMed ID: 26654672
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
[TBL] [Abstract][Full Text] [Related]
10. [Limited sampling strategy models for estimating AUC for amlodipine in Chinese healthy volunteers].
Wang K; Sheng YC; He YC; Yang J; Zhang M; Xu L; Shi JM; Zheng QS
Yao Xue Xue Bao; 2010 Dec; 45(12):1582-6. PubMed ID: 21351501
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
[TBL] [Abstract][Full Text] [Related]
12. Single-pill combination of amlodipine and valsartan in the management of hypertension.
Flack JM; Hilkert R
Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
[TBL] [Abstract][Full Text] [Related]
13. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.
Kwak HH; Kim JO; Chung HK; Choi SM; Kim JH; Kwon JW; Yoo M; Lee JH; Lee MG
Biopharm Drug Dispos; 2006 Apr; 27(3):141-5. PubMed ID: 16400620
[TBL] [Abstract][Full Text] [Related]
15. Amlodipine-induced myoclonus.
Wallace EL; Lingle K; Pierce D; Satko S
Am J Med; 2009 Apr; 122(4):e7. PubMed ID: 19332219
[No Abstract] [Full Text] [Related]
16. Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction.
Yoo HH; Kim IS; Yoo DH; Kim DH
J Hypertens; 2016 Jan; 34(1):156-62. PubMed ID: 26630218
[TBL] [Abstract][Full Text] [Related]
17. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Davis BR; Whelton PK;
N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
[No Abstract] [Full Text] [Related]
18. Development of a pharmacokinetic interaction model for co-administration of simvastatin and amlodipine.
Son H; Lee D; Lim LA; Jang SB; Roh H; Park K
Drug Metab Pharmacokinet; 2014; 29(2):120-8. PubMed ID: 23965645
[TBL] [Abstract][Full Text] [Related]
19. Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration.
Rausl D; Fotaki N; Zanoski R; Vertzoni M; Cetina-Cizmek B; Khan MZ; Reppas C
J Pharm Pharmacol; 2006 Jun; 58(6):827-36. PubMed ID: 16734984
[TBL] [Abstract][Full Text] [Related]
20. Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.
Koya Y; Uchida S; Machi Y; Shobu Y; Namiki N; Kotegawa T
Eur J Clin Pharmacol; 2016 Nov; 72(11):1353-1361. PubMed ID: 27491774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
